
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Healthcare
Hospitals / Medical Services
35,047 Cr
Low Risk
41.3
58.1
2.3
8.6
2,371.60
1,296.40
Sales CAGR
1Y
9.26%
3Y
14.18%
5Y
9.90%
10Y
10.43%
Profit CAGR
1Y
0.13%
3Y
47.78%
5Y
44.79%
10Y
25.29%
ROE
TTM
20.82%
3Y
25.28%
5Y
22.33%
10Y
17.41%
ROCE
TTM
17.75%
3Y
20.96%
5Y
18.70%
10Y
15.36%
Narayana Hrudayalaya Ltd (NH) is currently trading at 1,720.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Narayana Hrudayalaya Limited, founded by Dr. Devi Prasad Shetty, operates a network of multispeciality and super speciality hospitals across India and overseas, focusing on accessible and affordable healthcare services. In Q2 FY26, the company reported a robust YoY revenue growth of 20.3%, achieving consolidated operating revenues of ₹ 16,438 Mn, driven by strategic operational improvements and increased patient throughput. The company is actively investing in capacity expansion, with significant projects underway in Bangalore and Kolkata aimed at increasing bed capacity, indicating a strategic push to cater to rising healthcare demand. A notable achievement in Q2 FY26 was completing over 1000 robotic surgeries, underscoring Narayana's commitment to adopting advanced surgical technologies and setting national benchmarks in minimally invasive procedures. Narayana's international operations, particularly in Cayman, demonstrated substantial growth, with a reported 70% revenue increase, highlighting its effective insurance product offerings and potential for future expansion.
Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,296.40 and a high of ₹2,371.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Narayana Hrudayalaya Ltd has a market capitalization of approximately 35,046.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Narayana Hrudayalaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.34 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Narayana Hrudayalaya Ltd (NH) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 35,046.86 Cr, Narayana Hrudayalaya Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Narayana Hrudayalaya Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 41.34. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Narayana Hrudayalaya Ltd pays dividends with a current dividend yield of 0.26%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.
Key risks associated with Narayana Hrudayalaya Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
2
Neutral
5
Bullish
7
Bearish
34
Neutral
5
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Upcoming Result Date: Feb 12, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK

Market Cap
₹ 35,047 Cr
P/E
41.34
Turned 1 L into 3.38 L in last 5 Years
Merger/Acquisition
2 hours ago
Scheme of Amalgamation Announcement
Narayana Hrudayalaya Limited has published a newspaper advertisement regarding the scheme of amalgamation with Meridian Medical Research & Hospital Ltd., following NCLT approval.
Board Meeting Outcome
1 day ago
Board Meeting for Q3 Financial Results Approval
Narayana Hrudayalaya Ltd will hold a board meeting on February 13, 2026, to approve the un-audited standalone and consolidated financial results for Q3 ended December 31, 2025.